-
Something wrong with this record ?
Tick-borne encephalitis: A comprehensive review of the epidemiology, virology, and clinical picture
G. Chiffi, D. Grandgirard, SL. Leib, A. Chrdle, D. Růžek
Language English Country England, Great Britain
Document type Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
37392370
DOI
10.1002/rmv.2470
Knihovny.cz E-resources
- MeSH
- Encephalitis, Tick-Borne * epidemiology prevention & control MeSH
- Quality of Life MeSH
- Humans MeSH
- RNA MeSH
- Public Health MeSH
- Encephalitis Viruses, Tick-Borne * genetics MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Tick-borne encephalitis virus (TBEV) is a flavivirus commonly found in at least 27 European and Asian countries. It is an emerging public health problem, with steadily increasing case numbers over recent decades. Tick-borne encephalitis virus affects between 10,000 and 15,000 patients annually. Infection occurs through the bite of an infected tick and, much less commonly, through infected milk consumption or aerosols. The TBEV genome comprises a positive-sense single-stranded RNA molecule of ∼11 kilobases. The open reading frame is > 10,000 bases long, flanked by untranslated regions (UTR), and encodes a polyprotein that is co- and post-transcriptionally processed into three structural and seven non-structural proteins. Tick-borne encephalitis virus infection results in encephalitis, often with a characteristic biphasic disease course. After a short incubation time, the viraemic phase is characterised by non-specific influenza-like symptoms. After an asymptomatic period of 2-7 days, more than half of patients show progression to a neurological phase, usually characterised by central and, rarely, peripheral nervous system symptoms. Mortality is low-around 1% of confirmed cases, depending on the viral subtype. After acute tick-borne encephalitis (TBE), a minority of patients experience long-term neurological deficits. Additionally, 40%-50% of patients develop a post-encephalitic syndrome, which significantly impairs daily activities and quality of life. Although TBEV has been described for several decades, no specific treatment exists. Much remains unknown regarding the objective assessment of long-lasting sequelae. Additional research is needed to better understand, prevent, and treat TBE. In this review, we aim to provide a comprehensive overview of the epidemiology, virology, and clinical picture of TBE.
Department for BioMedical Research University of Bern Bern Switzerland
Department of Experimental Biology Faculty of Science Masaryk University Brno Czech Republic
Department of Infectious Diseases Hospital Ceske Budejovice Ceske Budejovice Czech Republic
Faculty of Health and Social Sciences University of South Bohemia Ceske Budejovice Czech Republic
Institute for Infectious Diseases University of Bern Bern Switzerland
Royal Liverpool University Hospital Liverpool UK
Veterinary Research Institute Emerging Viral Diseases Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016381
- 003
- CZ-PrNML
- 005
- 20231026105939.0
- 007
- ta
- 008
- 231013s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/rmv.2470 $2 doi
- 035 __
- $a (PubMed)37392370
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Chiffi, Gabriele $u Department for BioMedical Research, University of Bern, Bern, Switzerland $u Institute for Infectious Diseases, University of Bern, Bern, Switzerland $1 https://orcid.org/0009000227052479
- 245 10
- $a Tick-borne encephalitis: A comprehensive review of the epidemiology, virology, and clinical picture / $c G. Chiffi, D. Grandgirard, SL. Leib, A. Chrdle, D. Růžek
- 520 9_
- $a Tick-borne encephalitis virus (TBEV) is a flavivirus commonly found in at least 27 European and Asian countries. It is an emerging public health problem, with steadily increasing case numbers over recent decades. Tick-borne encephalitis virus affects between 10,000 and 15,000 patients annually. Infection occurs through the bite of an infected tick and, much less commonly, through infected milk consumption or aerosols. The TBEV genome comprises a positive-sense single-stranded RNA molecule of ∼11 kilobases. The open reading frame is > 10,000 bases long, flanked by untranslated regions (UTR), and encodes a polyprotein that is co- and post-transcriptionally processed into three structural and seven non-structural proteins. Tick-borne encephalitis virus infection results in encephalitis, often with a characteristic biphasic disease course. After a short incubation time, the viraemic phase is characterised by non-specific influenza-like symptoms. After an asymptomatic period of 2-7 days, more than half of patients show progression to a neurological phase, usually characterised by central and, rarely, peripheral nervous system symptoms. Mortality is low-around 1% of confirmed cases, depending on the viral subtype. After acute tick-borne encephalitis (TBE), a minority of patients experience long-term neurological deficits. Additionally, 40%-50% of patients develop a post-encephalitic syndrome, which significantly impairs daily activities and quality of life. Although TBEV has been described for several decades, no specific treatment exists. Much remains unknown regarding the objective assessment of long-lasting sequelae. Additional research is needed to better understand, prevent, and treat TBE. In this review, we aim to provide a comprehensive overview of the epidemiology, virology, and clinical picture of TBE.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a klíšťová encefalitida $x epidemiologie $x prevence a kontrola $7 D004675
- 650 _2
- $a kvalita života $7 D011788
- 650 12
- $a viry klíšťové encefalitidy $x genetika $7 D004669
- 650 _2
- $a RNA $7 D012313
- 650 _2
- $a veřejné zdravotnictví $7 D011634
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Grandgirard, Denis $u Institute for Infectious Diseases, University of Bern, Bern, Switzerland
- 700 1_
- $a Leib, Stephen L $u Institute for Infectious Diseases, University of Bern, Bern, Switzerland
- 700 1_
- $a Chrdle, Aleš $u Department of Infectious Diseases, Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic $u Faculty of Health and Social Sciences, University of South Bohemia, Ceske Budejovice, Czech Republic $u Royal Liverpool University Hospital, Liverpool, UK
- 700 1_
- $a Růžek, Daniel $u Veterinary Research Institute, Emerging Viral Diseases, Brno, Czech Republic $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic $1 https://orcid.org/0000000346552380 $7 stk2008441707
- 773 0_
- $w MED00004118 $t Reviews in medical virology $x 1099-1654 $g Roč. 33, č. 5 (2023), s. e2470
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37392370 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026105933 $b ABA008
- 999 __
- $a ok $b bmc $g 2000100 $s 1202743
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 33 $c 5 $d e2470 $e 20230701 $i 1099-1654 $m Reviews in medical virology $n Rev Med Virol $x MED00004118
- LZP __
- $a Pubmed-20231013